Orthogen, LLC Will Continue to Develop High-Quality Nanotechnologies for Bone Regeneration Into the New Year

Logo

Springfield, NJ -- (SBWire) -- 03/20/2018 --In the years since its founding within the research labs of New York University, Orthogen, LLC has been pioneering within the biomedical industry. After branching off from BioLok International in 2007, the company went independent, researching and manufacturing the most innovative of dental bone grafting materials for dental and orthodontic procedures. Headed into the New Year, their scientists will continue to develop the highest quality nanotechnologies for bone regeneration.

Harnessing a wealth of scientific knowledge and expertise, as well as partnerships with Rutgers University and the New York University School of Dentistry, Orthogen, LLC has produced a line of unparalleled dental grafting materials. Including the company's patented NanoGen as well as DentoGen, the nanocrystalline calcium sulfate-based materials assist in dental implant surgeries and tissue regeneration.

Utilizing NanoGen and DentoGen, dentists have the means to guarantee their success during surgeries—greatly increasing the chance of osseointegration. With an Orthogen developed material, oral surgeries become smooth and routine procedures. The biocompatibility and biodegradability of grafting materials like DentoGen prevent particle migration, making itself an ideal solution for periodontic and endodontic bone grafting applications.

The stand-alone grafting material, NanoGen allows bone defects to be filled with regenerated vital bone within the span of 12 weeks. Because of its reliability as a dental grafting material, NanoGen has earned Orthogen the reputation as the best dental implant company.

Any dentists or orthodontists interested in utilizing the innovative nanotechnologies may contact Orthogen, LLC at 1-877-336-8643.

About Orthogen, LLC
Originally a division of BioLok International, which is now merged with BioHorizons, Orthogen, LLC was established in 2007 to develop and market next generation bone-grafting products for orthopedic and dental applications.

To inquire about the company's products and technologies, please call 877-336-8643, or visit http://orthogencorp.com/.

Media Relations Contact

Sachin Mamidwar
http://orthogencorp.com/

View this press release online at: http://rwire.com/951334